MONTERREY, Mexico, Feb. 15, 2018 -- Deutsche Bank Mexico, S.A., Banking institution, Trust Division F/1616 or Fibra Inn (BMV:FINN13) (ADR OTC:DFBRY) (“Fibra Inn” or “the Company”), a Mexican real estate investment trust internally managed specializing in the hotel industry serving the business traveler with global brands, announced that it has successfully carried out the Debt Tender Offering of a portion of the issuance FINN15 offering as well as the simultaneous debt issuance in the local markets for Ps. 2 billion, in the following manner:
- A New Debt Issuance of Unsecured Trust Certificates (CBFs) for Ps. 2 billion at a fixed rate of 9.93% (base rate of 7.73% plus 220 basis point spread) for a 10-year maturity due on February 2, 2028; ticker symbol FINN18.
- At the same time, the Company completed a Debt Tender Offer, whereby it completed the partial and early repurchase of 18,753,500 FINN15 securities, which were due to mature in 2021, for a total of Ps. 1,875.4 million. The new amount of the FINN15 tender offer is Ps. 1 billion; bringing the total amount of both issuances to Ps. 3 billion.
As was discussed previously, the purpose of these transactions was to improve the Company’s financial profile. As such, resources of the FINN18 issuance were used to repurchase FINN15 securities, which were issued in September 2015. The remaining Ps. 124.7 million will be used for the following:
- Ps. 29.0 million for the expenses related to the FINN18 issuance;
- Ps. 3.5 million for the expenses related to the public tender offer for the repurchase of FINN15;
- Ps. 12.3 million for the payment of interest related to the FINN15 coupon that is in effect;
- Ps. 79.9 million for corporate purposes that will be allocated towards investments in existing hotels.
The new issuance for FINN18 was oversubscribed by 1.44 times, which compares favorably with issuances for other securities and other fibras, also rated AA-(mex) on a local scale by Fitch Ratings and HR AA+ on a local scale by HR Ratings.
Miguel Aliaga, Chief Financial Officer, stated: “With this new debt issuance, Fibra Inn improves its overall financial conditions and upholds its commitment to continue maintaining loan-to-value levels of under 30%. The spread and the demand of the book reflect the confidence investors have in Fibra Inn, as its name is synonymous with the successful execution of its business strategy and contribution to value generation.”
Contacts:
In Monterrey, Mexico:
Lizette Chang, IRO
Fibra Inn
Tel: 52 1 (81)1778-5926
Email: [email protected]
In New York:
Maria Barona
i-advize Corporate Communications, Inc.
Tel: (212) 406-3691
Email: [email protected]
Twitter: @fibrainn.mx


Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports
How Marco Pharma International Preserves German Homeopathic Traditions in America
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
U.S. Judge Allows Jeffrey Epstein Sex Trafficking Lawsuit Against Bank of America to Proceed
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 



